Clinical Trial Update: Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BL-8040 for mobilizing donor hematopoietic stem cells to enable allogeneic transplantation in patients with advanced hematolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Disease
• Multiple Myeloma
• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm
• Non-hodgkin Lymphoma

Drugs mentioned

• BL-8040

Snippet

Sponsor: Washington University School of Medicine | Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-05-01